Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 227

8. REFERENCES

Aanandhi MV, Mansoori MH, Shanmugapriya S, George S, Shanmugasundaram

P. Synthesis and in-vitro antioxidant activity of substituted pyridinyl 1,3,4-

oxadiazole derivatives. Res J Pharm Biol Chem Sci. 2010;1083-1090.

Abadi AH, Eissa AA, Hassan GS. Synthesis of novel 1,3,4-trisubstituted pyrazole

derivatives and their evaluation as antitumor and angiogenic agents. Chem Pharm

Bull. 2003;51:838-844.

Abdrabbo MK. NSAIDS associated GI-complications. Gastrointestinal

Endoscopy. 2005;3:49-52

Adamczak R, Porollo A, Meller J. Combining prediction of secondary structure

and solvent accessibility in proteins. Proteins. 2005;59:467-475.

Adelstein GW, Yen CH, Dajani EZ, Bianchi RG, 3,3-Diphenyl-3-(2-alkyl-1,3,4-

oxadiazol-5-yl)-propylcycloakylamines, a novel series of anti-diarrheal agents. J

Med Chem. 1976;19:1221-1225.

Ainsworth C. 1,3,4-Oxadiazole. J Am Chem Soc. 1965;87:5800-5801.

Alexandru TB, Padmakar VK, Aziz S. Comparison of topological indices based

on iterated sum versus product operations. Iran J Math Chem. 2010;1:43-67.

Ali MA and Yar MS. Oxadiazole Mannich bases: synthesis and antimycobacterial

activity, Bioorg Med Chem Lett. 2007;17:3314-3316.

Al-Omar MA. Synthesis and antimicrobial activity of new 5-(2-thienyl)-1,2,4-

triazoles and 5-(2-thienyl)-1,3,4-oxadiazoles and related derivatives. Molecules.

2010;15:502-514.

Amero CD, Byerly DW, McElroy CA, Simmons A, Foster MP. Ligand-induced

changes in the structure and dynamics of Escherichia Coli peptide deformylase.

Biochemistry. 2009;48:7595-7607.

Amir M and Kumar S. Synthesis and evaluation of anti-inflammatory, analgesic

and lipid peroxidation properties of ibuprofen derivatives. Acta Pharm.

2007;57:31-45.

Amir M and Shikha K. Synthesis and anti-inflammatory, analgesic, ulcerogenic

and lipid peroxidation activities of some new 2-[(2,6-dichloroanilino)

phenyl]acetic acid derivatives. Eur J Med Chem. 2004;39:535-545.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 228

Amir M, Javed SA and Kumar H. Synthesis of some newer analogues of 4-

hydroxyphenyl acetic acid as potent anti-inflammatory agents. J Chine Chem Soc.

2008;55:201-208.

Amir M, Javed SA, Kumar H. Synthesis of some novel 1,3,4-oxadiazole as

potential anti-inflammatory agents,. Indian J Chem. 2007;46:1014-1019.

Anand N. Burger’s medicinal chemistry, 4th

ed. Wiley-Interscience, New York;

1979.

Ananikov VS, Robert S, Keiji M, Musaev GD. Can steric effects induce the

mechanism switch in the rhodium-catalyzed imine boration reaction. A density

functional and ONIOM study. Organometallics. 2005;24:19-38.

Arumugam M, Muthuswamy U, Kuppusamy A, Thirumalaisamy S, Varadharajan

S. In silico docking studies of cyclooxygenase inhibitory activity of commercially

available flavonoids. Asian J Pharm Life Sci. 2012; 2:174

Atkinson AJ, Darrell RA, Danies CE, Dedrick RL, Markey SP. Principles of

clinical pharmacology, 2nd

ed., Elsevier, Book Aid International Sabre

Foundation, U.K; 2007.

Ausaf A, Husain A, Ajmal M, Ahuja P. Fenbufen based 3-[5-(substituted aryl)-

1,3,4-oxadiazol-2-yl]-1-(biphenyl-4-yl)propan-1-ones as safer anti-inflammatory

and analgesic agents. Eur J Med Chem. 2009;44:3798-3804.

Bakhle YS and Botting RM. Cyclooxygenase-2 and its regulation in

inflammation. Med Inflamm.1996; 5:305-323.

Bali A, Ohri R, Deb PK. Synthesis, evaluation and docking studies on 3-alkoxy-4-

methanesulfonamido acetophenone derivatives as non ulcerogenic anti-

inflammatory agents. Eur J Med Chem. 2012;49:397-405.

Bari SB, Aggarwal AO, Patil UK. Synthesis and pharmacological evaluation of

some novel isatin derivatives foe antimicrobial activity. J Sci Islam Repub Iran.

2008;19:217-221.

Bennett DL, Averill S, Priestley JV, McMahon SB. Postnatal changes in the

expression of TrkA high affinity NGF receptor in primary sensory neurons. Eur J

Neurosci. 1998;8:2204-2208

Bennett PN and Brown MJ. Clinical pharmacology, 10th

ed. Churchill

Livingstone, New York; 2009.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 229

Beydoun A and Backonja MM. Mechanistic stratification of antineuralgic agents.

J Pain Symptom Manage. 2003;25:18-30.

Bhandari SV, Bothara KG, Raut MK, Patil AA, Sarkate AP, Mokale VP. Design,

synthesis and evaluation of anti-inflammatory, analgesic and ulcerogenicity

studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and schiff bases

of diclofenac acid as nonulcerogenic derivatives. Bioorg Med Chem.

2008;16:1822-1831.

Bhardwaj N, Saraf SF, Sharma P and Kumar P. Synthesis, evaluation and

characterization of some 1, 3, 4-oxadiazoles as antimicrobial agents. E-J Chem.

2009;6:1133-1138.

Bhat MA, Al-Omar MA, Siddiqui N. Synthesis, anticonvulsant and neurotoxicity

of some novel 1,3,4-oxadiazole derivatives of phthalimide. Der Pharma Chemica.

2010;2:1-10.

Bhat MA, Siddiqui N, Khan SA. Synthesis of novel 3-(4-acetyl-5h/methyl-5-

substituted phenyl-4,5-dihydro-1,3,4-oxadiazol-2-yl)-2H-chromen-2-ones as

potential anticonvulsant agents. Acta Pol Pharm. 2008;65:235-239.

Bhatia NM, Mahadik KR, Bhatia MS. Exploring the influence of steric, electronic

and lipophilic descriptors of 1,3-diarylpropenones on their anti-inflammatory

activity. DARU. 2010;18:230-236.

Black JG. Growth and culturing the bacteria. Microbiology principle and

exploration. 4th

ed. New Jersey: Prentice Hall; 1999.

Bokoch GM. Chemoattractant signaling and leukocyte activation. Blood.

1995;86:1649-1660.

Borkotoky S. Docking studies on HIV integrase inhibitors based on potential

ligand binding sites. Int J Bioinformatics Biosciences.2012;2:21-29.

Bostrom J, Hogner A, Llins, Wellner E, Plowright AT, Oxadiazoles in medicinal

chemistry. J Med Chem. 2012;55:1817-1830.

Bray MA, Ford-Hutchinson AW, Smith MJ. In: SRA-A and Leukotrienes. Ed. P J

Piper. Research Studies Press, Chichester; 1981.

Bridges D, Thompson SW, Rice AS. Mechanisms of neuropathic pain. Brit J

Anaesth. 2001:87:12-26.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 230

Buttgereit F, Burmester G, Simon S. Gastrointestestinal toxic side effects of non-

steroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors. Am J

Med. 2001;110:135-195

Carlos TM and Harlan JM. Leukocyte-endothelial adhesion molecules. Blood.

1994;84:2068-2101.

Carol P. Essentials of pathophysiology: concepts of altered health states,

Hagerstown, Lippincott Williams & Wilkins; 2007.

Carrieri-Kohlman V, Lindsey AM, West CM. Pathophysiological phenomena in

nursing, 3rd

ed. St. Louis, MO: Saunders; 2003

Carter SJ. Basics of Microbiology, Cooper and Gunn’s Tutorial Pharmacy. 6th

ed.

CBS Publishers and Distributors; 2005.

Casimir CM and Teahan CG, The respiratory burst of neutrophils and its

deficiency. Immunopharmacology of neutrophils. Academic Press Limited,

London; 1994.

Chawla P, Maheshwari R, Saraf SA. Synthesis and evaluation of anti-

inflammatory and antimicrobial activity of 2,5-disubstituted-1,3,4-oxadiazoles.

Der Pharma Chemica. 2010;2:38-45.

Christopher JS, Yan Z, Carol M, Muhammad J, Isakson PC. Pharmacological

analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad. Sci.

1998;95:13313-13318.

Chu CH, Sun XW, Zhang ZY, Li ZC, Liao RA. Synthesis and biological activities

of -heterocyclyl--(1H-1,2,4-triazol-1-yl)acetophenones. Chinese Chem Lett.

1999; 10:361-364.

Cioli V, Putzolu S, Rossi V, Barcellona PS, Corradino C. The role of direct tissue

contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in

rats. Toxicol Appl Pharmacol. 1979;50:283-289.

Connolly ML. Solvent-accessible surface of proteins and nucleic acids. Science.

1983;221:709-713.

Cotran K and Collins R. Pathologic basis of disease. Philadelphia: W.B Saunders

Company, USA; 1998.

Dabiri M, Salehi P, Baghbanzadeh M, Bahramnejad M. A facile procedure for the

one-pot synthesis of unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles.

Tetrahedron Lett. 2006;47:6983-6986.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 231

Delves PJ, Roitt IM. The immune system. Engl J Med.2000;343:37-49.

Denmark SE, Weber T, David W, Piotrowski. Organocerium addition to SAMP-

Hydrazones: General synthesis of chiral amines. J Chem Soc. 1987;109:2224-

2225.

Deruiter J. Non-steroidal anti-inflammatory drugs (NSAIDS)-principles of drug

action. Fall; 2002;2:1–25.

Desai NC, Bhavsar AM, Shah MD, Saxena A. Synthesis and QSAR studies of

thiosemicarbazide,1,2,4-triazole, 1,3,4-thiadiazole derivatives as potential

antibacterial agents, Indian J Chem. 2008;47:579-589.

Doherty NS and Janusz MJ. Neutrophil proteases: their physiological and

pathological roles. Immunopharmacology of neutrophils. Academic Press

Limited, London; 1994.

Dormandy T. The worst of evils: man's fight against pain. New Haven, Conn:

Yale University Press; 2006.

Dravyakar BR. Kawade DP, Khedekar PB, Bhusari KP. Design and synthesis of

some new diphenylaminoisooxazolines as potent anti-inflammatory agent. Indian

J Chem. 2008;47:1559-1567.

Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett.

Advances in neuropathic pain-diagnosis, mechanisms and treatment

recommendations. Arch Neuro. 2003;60:1524-1534.

Elkaim L, Grimaud, Jana LN, Tirla C, Nitrohydrazones: Versatile intermediates

for phosphonate derivatives formation from primary nitro compounds, Tetrahed

Lett. 2002;43:2037-2038.

El-Sayed WA, Ali OM, Hendy HA, Abdel-Rahman AA. Synthesis and

antimicrobial activity of new 2,5-disubstituted 1,3,4-oxadiazoles and 1,2,4

triazoles and their sugar derivatives. Chin J Chem. 2012;30:77-83.

El-Sayeda WA, El-Essawyb FA, Alib OM, Nasrb BS, Abdallac MM, Abdel-

Rahmanb A, Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives

and their acyclic nucleoside analogues. Z Naturforsch. 2009;64:773-778.

Ericsson H and Sherris JC. Antibiotic sensitivity testing report of an international

collaborative study. Acta Pathol Microbiol Scand. 1971;217:1-90.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 232

European commission health & consumer protection directorate-general

Directorate E-Food Safety: plant health, animal health and welfare, international

questions E1-Plant health, Oxadiargyl; 2002.

Ferwanah AR. Synthesis and x-ray crystal structure analysis of substituted-2,3-

dihydro-1,3,4-oxadiazoles via reaction of acetone- and cycloalkanone

benzoylhydrazones with phenylisocyanate. J Islam Univ Gaza. 2005;13:35-45.

Fine PG and Ashburn MA. Functional neuroanatomy and nociception. The

management of pain. Churchill Livingstone. New York; 1998.

Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ. Leukotriene

B, a potent chemokinetic and aggregating substance released from

polymorphonuclear leukocytes. Nature. 1980;17:264-265.

Ford-Hutchinson AW. Leukotriene B4 and neutrophil function: a review. J R Soc

Med. 1981;74: 831-833.

Frank PV, Girish KS, Kalluraya B. Solvent-free microwave-assisted synthesis of

oxadiazoles containing imidazole moiety. J Chem Sci. 2007;119:41-46.

Franski R. Biological activities of the compounds bearing 1,3,4-oxa(thia)diazole

ring. Asian J Chem. 2005;17:2063-2075.

Fuloria NK, Singh V, Shaharyar M, Ali M. Synthesis and antimicrobial evaluation

of some new oxadiazoles derived from phenylpropionohydrazides. Molecules.

2009:14:1898-1903.

Gaonkar SL, Rai KM, Prabhuswamy B. Synthesis and antimicrobial studies of a

new series of 2-4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl-5-substituted-1,3,4-

oxadiazoles. Eur J Med Chem. 2006;41:841-846.

Gaud RS and Gupta GD. Practical microbiology. 5th

ed. Nirali Prakashan; 2006.

Gauto DF, Carlos M, Dumas VG, Lucia A, Bustamante JP, Turjanski AG, Marti

MA. Determining free energies of protein-ligand binding and

association/dissociation processes using computer simulations. World Res J

peptide protein. 2012;1:21-32.

Geronikaki AA, Lagunin AA, Hadjipavlou-Litina DI, Eleftheriou PT, Filimonov

DA, Poroikov VV, Alam I, Saxena AK. Computer-aided discovery of anti-

inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase Inhibition. J

Med Chem. 2008;51:1601-160.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 233

Gilroy DW, Colville-Nash PR, Willis D, Chivers J. Clark MJP, Willoughby DJ.

Inducible cyclooxygenase may have anti-inflammatory properties. Nature Med.

1999;5:698-701.

Giugliano D, Marfella R, Coppola L. Vascular effects of acute hyperglycemia in

humans are reversed by L-arginine. Evidence for reduced availability of nitric

oxide during hyperglycemia.Circulation. 1997;95:783-790.

Goodman and Gillman. Manual of pharmacology and therapeutics. McGraw Hill,

NewDelhi; 2007.

Goodman and Gilman’s. The pharmacological basis of therapeutics, 11th

ed.

McGraw Hill; 2008.

Granger DN and Kubes P. The microcirculation and inflammation: modulation of

leukocyte-endothelial cell adhesions. J Leukoc Biol. 1994;55:662-675.

Gudasi K, Patil M, Vadavi R, Shenoy R, Patil S. Transition metal complexes with

a new tridentate ligand, 5-[6-(5-mercapto- 1,3,4-oxadiazol-2-yl)pyridin-2-yl]-

1,3,4-oxadiazole-2-thiol. J Serb Chem Soc. 2007;72:357–366.

Gupta RR, Kumar M, Gupta V. Five membered heterocycles. Heterocyclic Chem.

1st ed. India: Springer; 2005.

Halperin I, Ma B, Wolfson H, Nussinov R. Principles of docking: an overview of

search algorithms and a guide to scoring functions. Proteins. 2002;4:409-443.

Han WS, Lee JK, Lee JS, Hahn HG, Yoon CN. Study of thiazoline derivatives for

the design of optimal fungicidal compounds using multiple linear regressions

(MLR). Bull Korean Chem Soc. 2012;33:1703-1706.

Hansch LA, Elkins D. Partition coefficients and their uses. Chem Rev.

1971;71:525-616.

Harfenist M, Heuser DJ, Joyner CT, Batchelor JF, White HL. Selective inhibitors

of monoamine oxidase structure activity relationship of tricyclics bearing

imidazoline, oxadiazole or tetrazole groups. J Med. Chem. 1996;39:1857-1863.

Harry WS, Paul JV, John JL. Culturing Microorganism Microbes in action. A

Laboratory manual of Microbiology. 4th

ed. New York: WH Freeman and

Company; 1991.

Haslett C, Savill JS, Meagher L. The neutrophil. Curr Opin Immunol. 1989;2:10-

18.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 234

Haslett. C and Henson P. Resolution of inflammation. The molecular and cellular

biology of wound repair. Plenum Press, New York; 1996.

He D, Zhu Y, Yang Z, Hu A, Cao G. Synthesis, characterization and optical

properties of novel 2,5-bis[4-(2-(arylvinyl)phenyl]-1,3,4-oxadiazoles. Turk J

Chem. 2009;33:393-397.

Higgs GA, Salmon JA, Spayne JA. The inflammatory effects of hydroperoxy and

hydroxy acid products of arachidonate lipoxygenase in rabbit skin. J. Pharmac.

1981;74:429-433.

Howard SS. Arachidonic acid pathway in nociception review. J Supp. Onco.

2006;6:267-276.

http://proteopedia.org/wiki/index.php/1g2a

http://proteopedia.org/wiki/index.php/1jxa

http://www.proteopedia.org/wiki/index.php/1cx2

Husain A and Mohammed A. Synthesis of novel 1,3,4-oxadiazole derivatives and

their biological properties. Acta pharm.2009;59:223-233.

Husain A, Ahmad FJ, Ajmal M and Ahuja P. Synthesis of 1-(4-phenoxyphenyl)-3-

[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]propan-1-ones as safer anti-

inflammatory and analgesic agents. Eur J Med Chem. 2009; 44:3798-3804.

Husain A, Ahuja P, Sarafroj. Synthesis and biological evaluation of β-Aroyl

propionic acid based 1,3,4-oxadiazole. Indian J Pharm Sci. 2009;71:62-66.

Husain A, Sarafroz M, Ahuja P. 2-[3-(4-Chloro/ethyl phenyl)propan-3-one]-5-

(substituted phenyl)-1,3,4-oxadiazoles: synthesis and biological evaluation. Acta

Pol Pharm. 2008;65:527-534.

Husain MI, Kumar A, Srivastava RC. Synthesis of N-(2-naphthyloxyacetyl)-

thiosemicarbazides and 2-arylamino-5-(2-naphthyloxymethyl)-1,3,4-

thiadiazoles/oxadiazoles as oral hypoglycemic agents. Curr Sci. 1986;55:644-646.

Husain, M. S. Y. Khan, S. M. Hasan, M. M. Alam, 2-Arylidene-4-(4-phenoxy-

phenyl)but-3-en-4-olides: synthesis, reactions and biological activity, Eur J Med

Chem. 2005;40:1394-1404.

Hwang JY, Choi H, Lee D, Gong Y. Solid-phase synthesis of 1,3,4-oxadiazole

and 1,3,4-thiadiazole derivatives via selective, reagent-based cyclization of

acyldithiocarbazate resins. J Comb Chem. 2005;7:816-819.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 235

Inderba Indian drugs (Indian Drugs manufacturing association 102B Poonam

chambers, Dr. A. B. Rd., Worli, Bombay, India). 1982;19:301.

Indian Pharmacopoeia. Cotroller of publication, Govt. of India. Vol-I, Ghaziabad;

2007.

Jain N, Pathak DP, Mishra P, Jain S. Syntheses and antibacterial studies of some

2-[5-(aryl)-[1,3,4]oxadiazole-2-ylsulfanyl]alkanoic acids. J Iran Chem Soc.

2009;6:77-81.

Jakubkiene V, Burbuliene MM, Mekuskiene G, Udrenaite E, Gaidelis P,

Vainilavicius P. Synthesis and anti-inflammatory activity of 5-(6-methyl-2-

substituted-4-pyrimidyloxymethyl)-1,3,4-oxadiazole-2-thiones and their 3-

morpholinomethyl derivatives. Farmaco. 2003;58:323-328.

Jeffrey and George A. An introduction to hydrogen bonding, Oxford University

Press; 1997.

Jha KK, Samad A, Kumar Y, Shaharya M, Khosa RL, Jain J, Bansal S. 3D QSAR

studies of 1,3,4-oxadiazole derivatives as antimycobacterial agents. Iran J Pharm

Res. 2009;8:163-167.

Jin L, Chen J, Song B, Chen Z, Yang S, Li Q, Hu D, Xu R.Synyhesis, structure,

and bioactivity of N’-substituted benzylidene-3,4,5-trimethoxybenzohydrazide

and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-

oxadiazole derivatives. Bioorg Med Chem Lett. 2006;16:5036-5040.

Joyashis B, Kuldeep P, Prafull T, Karthikeyan C. Design, synthesis and

characterization of novel 1,3,4-oxadiazole dimers from benzoic acids. Int J Chem

Tech Res. 2010;2:2055-2062.

Kadi AA, El-Brollosy NR, Al-Deeb OA, Habib EE, Ibrahim TM, El-Emam AA.

Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-

adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-

substituted-1,3,4-thiadiazoles. Eur J Med Chem. 2007;42:235-242.

Kalemba D and Kunicka A. Antibacterial and antifungal properties of essential

oils. Curr Med Chem. 2003;10:813-829.

Kalgutkar AS, Crews BC, Rowlinson SW, Garner C, Seibert K, Marnett LJ.

Aspirin-like molecules that covalently inactive cyclooxygenase-2. Science.

1998;280:1268-1270.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 236

Kalgutkar AS, Marnett AB, Crews BC, Remmel RP. Ester and amide derivatives

of non-steroidal anti-inflammatory drug, indomethacin as selective COX-2

inhibitors. J Med Chem. 2000;43:2860-2870.

Kamble RR and Sudha BS. Synthesis and pharmacological screening 5-methyl-3-

[p-(6'-aryl-2'-thioxo-1',2',5',6'-tetrahydropyrimidin-4'-yl)-phenyl]-3h-2-oxo-δ4-

1,3,4-oxadiazole, Indian J Pharm Sci. 2006;68:249-253.

Katzung GB. Basic and clinical pharmacology. International 9th

ed., Mc Graw

Hill, New York; 2004.

Kaur H, Kumar S, Singh I and Kumar A. Synthesis, characterization and

antibacterial activity of various substituted oxadiazolylpyrazolinyl/isoxazolinyl

coumarin derivatives. Int J Pharm Sci Res. 2010;1:58-65.

Kaur H, Kumar S, Singh I, Saxena KK, Kumar A. Synthesis, characterization and

biological activity of various substituted benzothiazole derivatives. Digest journal

of Nanomaterial Biostructures. 2010;5:67-76.

Kawade DP, Khedekar PB, Bhusari KP. QSAR studies of 6-aminopyrimidin-4-

one derivatives as anti-inflammatory agent. Int J Pharm Biomed Res. 2011;2:13-

16.

Kay AB. Overview of allergy and allergic diseases: with a view to the future. Br

Med Bull. 2000;56:843-864.

Khan KM, Ullah Z, Rani M,. Perveen S, Haider SM, Choudhary MI, Rahman A,

Voelter W. Microwave-assisted synthesis of 2,5-disubstituted1,3,oxadiazoles. Lett

Org Chem. 2004;1:50-52.

Khan MS and Husain A. Syntheses and reactions of some new 2-arylidene-4-

(biphenyl-4-yl)-but-3-en-4-olides with a study of their biological activity.

Pharmazie. 2002;57:448-452.

Konstantinos A. Testing for tuberculosis. Australian Prescriber. 2010;33:12-18.

Koparır M, Cetin A, Cansiz A. 5-Furan-2yl[1,3,4]oxadiazole-2-thiol, 5-furan-2yl-

4H-[1,2,4]triazole-3-thiol and their thiol-thione tautomerism. Molecules.

2005;10:475-480.

Kramer VI and Schunack W. Synthesis and H2-antagonistic activity of N,N-

substituted 1,3,4-oxadiazole-2,5-diamines. Arzneim-Forsch. 1986;36:1564-1567.

Kubinyi H. Similarity and dissimilarity: a medicinal chemist’s view, in 3D QSAR

in Drug Design. Kluwer Academic Publishers, Dordrecht; 1998.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 237

Kudelko A and Zieliǹski W. Microwave-assisted synthesis of 2-styryl-1,3,4-

oxadiazoles from cinnamic acid hydrazide and triethyl orthoesters. Tetrahedron

Lett. 2012;53:76-77.

Kuhns DB, Priel DA, Gallin JI. Loss of L-selectin (CD62L) on human neutrophils

following exudation in vivo. Cell Immunol. 1995;164:306-310.

Kumar RS, Pradeepchandran RV, Jayaveera KN. Computer aided discovery of

benzimidazole derivatives on peptide deformylase as antimicrobial agent using

HEX. Eur J Chem. 2011;2:558‐560.

Kumar RS, Pradeepchandran RV, Jayaveera KN. Docking studies of

benzimidazole derivatives on peptide deformylase and heptosyltransferase waac

as antibacterial agent. Int J Pharma Res Innovation. 2011;4:1-5.

Kumar V, Abbas AK, Fausto N, Mitchell RN. Robbins Basic Pathology. 8th

ed.

Saunders Elsevier; 2007.

Lanza FL. A guideline for the treatment and prevention of NSAID- induced

ulcers. Am J Gastroenterol. 1998;93:2037-2046.

Lee B and Richards FM. The interpretation of protein structures, estimation of

static accessibility. J Mol Bio. 1971;55:379-400.

Lee CH and Cho HI. Synthesis of 1,3,4-oxadiazoles having phenol or thiophenol

group. Bull Korean Chem Soc. 2001;22:1153-1155.

Lennette EH, Balows A, Hausler WJ, Shadowmy HJ. Manual of clinical

microbiology. 4th

ed. American Society for Microbiology: Washington, D. C. 995;

1985

Levine JD and Taiwo YO. Involvement of the mu-opiate receptor in peripheral

analgesia. Neuroscience. 1984;32:571-575.

Levine JD, Taiwo TO, Collins SD, Tam JK. Noradrenaline hyperalgesia is

mediated through interaction with sympathetic postganglionic neurone terminals

rather than activation of primary afferent nociceptors. Nature. 1986;323:158-l60.

Lindner M, Sippl W, Radwan AA. Pharmacophore elucidation and molecular

docking studies on 5-phenyl-1-(3-pyridyl)-1h-1,2,4-triazole-3-carboxylic acid

derivatives as COX-2 inhibitors. Sci Pharm. 2010;78:195-214.

Ma W and Eisenach JC. Morphological and pharmacological evidence for the role

of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur J

Neurosci. 2003;15:1037-47.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 238

Macaev F, Rusu G, Pogrebnoi S, Gudima A, Stingaci E, Vlad L, Shvets N,

Kandemirli F, Dimoglo A, Reynolds R. Synthesis of novel 5-aryl-2-thio-1,3,4-

oxadiazoles and the study of their structure anti-mycobacterial activities, Bioorg

Med Chem. 2005;13:4842-4850.

Malmberg AB and Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-

inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther.

1992;263:136-146.

Martin YC, Kofron JL, Traphagen LM. Do structurally similar molecules have

similar biological activity?. J Med Chem; 2002; 45:4350-4358.

Masferrer JL, Seibert K, Zweifel B, Needleman P. Proc Natl Acad Sci. USA;

1992.

Max B and Wolf B. Principles of optics: electromagnetic theory of propagation,

interference and diffraction of light. 7th

ed. Cambridge University Press; 1999.

Mayekar AN. Synthesis and antimicrobial studies on new substituted 1,3,4-

oxadiazole derivatives bearing 6-bromonaphthalene moiety. Int J Chem.

2010;2:38-54.

Mazouz F, Guiddari S, Burstein C, Mansuy D, Milcent R. 5-[4-

(Benzyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one derivatives and related analogues:

New reversible, highly potent and selective monoamine oxidase type B inhibitors.

J Med Chem. 1993;36:1157–1167.

Mazouz F, Lebreton L, Milcent R, Burskin C. 5-Aryl-1,3,4-oxadiazol-2-(3H)-one

derivatives and sulfur analogues as new selective and competitive monoamine

oxidase type B inhibitors. Eur Med Chem. 1990;25:659-671.

Melo SJ, Sobral SD, Lopes HL, Srivastav RM. Synthesis of some 3-aryl-1,2,4-

oxadiazoles carrying a protected L-alanine side chain. J Braz Chem Soc.

1989;9:465-468.

Milewski S. Glucosamine-6-phosphate synthase-the multi-facets enzyme.

Biochimica Biophysica Acta. 2002;1597:173-192.

Misra U, Hitkari A, Saxena AK, Gurtu S, Shanker K. Biologically active

indolylmethyl-1,3,4-oxadiazoles, 1,3,4-thiadiazoles, 4H-1,3,4-triazoles and 1,2,4-

triazines. Eur J Med Chem. 1996;31:629-634.

Mohammed IA, Subrahmanyam EV, Hareesh AR, Kowti R. Synthesis,

antimicrobial studies of some Schiff bases and novel 5- aryl (8-

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 239

quinolinoxymethyl)-1,3,4-oxadiazoles derivatives. Int. J Pharm Sci Bio.

2010;2:80-85.

Mohan H. Textbook of pathology, 5th

ed., Jaypee Brothers Medical Publishers,

New Delhi, India; 2005.

Momen-Roknabadi A, Sadeghi M, Pezeshk H, Marashi SA. Impact of residue

accessible surface area on the prediction of protein secondary structures.

Bioinform. 2008;9:357.

Mullican MD, Wilson MW, Connor DT, Kostlan CR, Schrier DJ, Dyer RJ. Design

of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles

and -1,2,4-triazoles as orally-active, nonulcerogenic anti-inflammatory agents. J

Med Chem. 1993;36:1090-1099.

Musser G, Amori G, Hutterer R, Kryštufek B, Yigit N, Mitsain G. Mus Musculus.

In: IUCN Red List of Threatened Species; 2008.

Muthumani P, Meera R, Agarwal SB, Devi P, Kameswari B, Muthuppandi R.

Synthesis of some derivatives of pyrimidine, oxadiazole and indole in

combination by conventional and microwave method. Der Pharma Chemica.

2009;1:167-177.

Nagalakshmi G. Synthesis, antimicrobial and anti-inflammatory activity of 2,5-

disubstituted-1,3,4-oxadiazoles, Indian J Pharm Sci. 2008;70:49-55.

Naik TA and Chikhalia KH. Studies on synthesis of pyrimidine derivatives and

their pharmacological evaluation. E-J Chem. 2007;4:60-66.

Narayana B, Vijayaraj KK, Ashlatha B, Kumari NS. Synthesis of some new 2-(6-

methoxy-2-naphthyl)-5-aryl-1,3,4- oxadiazoles as possible non-steroidal anti-

inflammatory and analgesic agents. Arch Pharm. 2005;338:373-377.

Nathan C. Points of control in inflammation. Nature. 2002;420:846-852.

Nicholson B. Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand.

2000;101:359-371.

Nigam R, Swarup S, Saxena VK, Singh HK, Synthesis and pharmacological

screening of some new 2-thio-3-(substituted-aminomethyl)-5-(3,5-dinitrophenyl)-

1,3,4-oxadiazoles. J Indian Chem Soc. 1992;69:692-693.

Nikolova N and Jaworska J. Approaches to measure chemical similarity-a review.

QSAR Comb Sci. 2003;22:1006-1026.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 240

Omar FA, Mahfouz NM, Rahman MA. Design, synthesis and anti-inflammatory

activity of some 1,3,4-oxadiazole derivatives. Eur J Med Chem. 1996;31:819-825.

Palomer A, Cabre F, Pascual J, Campos J. Identification of novel cyclooxygenase-

2 selective inhibitors using pharmacophore models. J Med Chem. 2002;45:1402-

1411.

Parakrama C and Taylor CR. General pathology, section II. The host response to

Injury, 3rd

ed. McGraw Hill, New York; 2005.

Parameswaran M, Thengungal KR, Gopalakrishnan S. Synthesis of coumarin

heterocyclic derivatives with antioxidant activity and in vitro cytotoxic activity

against tumour cells. Acta Pharm. 2009;59:159-170.

Parekh. J and Chanda S. In vitro antimicrobial activity of Trapa natans L. fruit

rind extracted in different solvents. Afr J Biotechnol. 2007;6:766-770.

Pasero C, Paice J, McCaffery M. Basic mechanisms underlying the causes and

effects of pain. 2nd

ed. St. Louis, MO: Mosby; 1999.

Patel NB and Patel JC. Synthesis and antimicrobial activity of 3-(1,3,4-oxadiazol-

2-yl)quinazolin-4(3H)-ones. Sci Pharm. 2010;78:171-193.

Patil UD, Nikum AP, Nagle PS, Mahulikar PP. Synthesis, antimicrobial and

antifungal activity evaluation of 2,6-diaryl-4-sec-aminonicotinonitrilesand 4-sec-

amino-6-aryl-2-(pyridin-yl)pyridine-3-carbonitriles i.e. bipyridines and their

docking study. J Pharm Res. 2012;5:1383-1386.

Pattan SR, Rabara PA, Pattan JS, Bukitagar AA, Wakale VS, Musmade DS.

Synthesis and evaluation of some novel substituted 1,3,4-oxadiazole and pyrazole

derivatives for antitubercular activity. Indian J Chem. 2009;48:1453-1456.

Portenoy RK and Kanner RM. Definition and assessment of pain. Pain

management: theory and practice. FA Davis Co. Philadelphia; 1996.

Pramanik SS and Mukherjee A. Synthesis and in-vitro serotonin-3-antagonist

activities of some new 1,3,4-oxadiazole-2-thiones. J Indian Chem Soc.

1998;75:53-54.

Prasanna S, Daga PR, Xie A, Doerksen RJ. Glycogen synthase kinase-3 inhibition

by 3-anilino-4-phenylmaleimides: insights from 3D-QSAR and docking. J

Comput Aided Mol Des. 2009;23:113-127.

Prescott LM, Harley JP, Klein DA. Microbial growth and metabolism.

Microbiology. 2nd

ed. England: Wm C Brown Publisher; 1990.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 241

Rajak H, Kharya DM, Mishra P. Synthesis of some novel oxadiazole and

oxadiazoline analogues for their anti-inflammatory activity, Yakuga Zasshi.

2007;127:1757-1764.

Rajasekaran S, Rao GK, Pai SP, Vedavathy J. Microwave assisted synthesis of

some 5-pyridyl-2-[(N-substituted phenyl) thioacetamido]-1,3,4-oxadiazoles as

antibacterial and antioxidant agents. J Chem Pharm Res. 2010;2:101-106.

Rakesh R, Somani A, Prabhakar Y, Shirodkar B. Oxadiazole: a biologically

important heterocycle. Der Pharma Chemica. 2009;1:130-140.

Ramalingam T, Deshmukh AA, Sattur PB. Synthesis and pharmacology of 2,5-

disubstituted-1,3,4-oxadiazoles. J Indian Chem Soc. 1981;58:269-271.

Ramazani A, Karimi Z, Souldozi A, Ahmadi Y. Four-component synthesis of

1,3,4-oxadiazole derivatives from N-isocyaniminotriphenylphosphorane, aromatic

carboxylic acids, aromatic bis-aldehydes, and secondary amines. Turk J Chem.

2012;36:81-91.

Ramazani A, Souldozib A. Iminophosphorane-mediated one-pot synthesis of

1,3,4-oxadiazole derivatives. Arkivoc. 2008;xvi:235-242.

Ramlingam T, Sattur PB. Synthesis and biological evaluation of α-(3-

pentadecylaryloxy)-propionic acids, their hydrazides and cyclic derivatives:

oxadiazoles and pyrroles. Indian Drugs. 1987;24:514–517.

Ravindra KC, Vagdevi HM, Vaidya VP, Basavaraj P. Synthesis, antimicrobial and

anti-inflammatory activities of 1,3,4-oxadiazole linked to naptho[2,1-b]furan.

Indian J Chem. 2006;45:2506-2511.

Red R, Homes D, Wayer J, Jone A. Sterile technique and microbial culture pour

plate technique. Practical skill in microbial culture pours plate technique. Practical

skill in biomolecular sciences. England:Addison Wesley Longman Limited; 1998.

Regina GL, Romano S, Valerio G, Antonio L, Ettore N, Olivia B, Paola T, Enzo

A. Synthesis, structure-activity relationships and molecular modeling studies of

new indole inhibitors of monoamine oxidases A and B. Bioorg Med Chem.

2008;22:9729-9740.

Regoli D, Drapeau G, Rovero P, Dion S, Orleans-Juste PD. The actions of

bradykinin antagonists on B1 and B2 receptor systems. Eur J Pharmacol.

1986;123:61-67.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 242

Rivera NR, Balsells J, Hansen KB. Synthesis of 2-amino-5-substituted-1,3,4-

oxadiazoles using 1,3-dibromo-5,5-dimethylhydantoin as oxidant. Tetrahedron

Lett. 2006;46:4889-4891.

Robins KC. Basic pathology. 6th

ed. Harcoure, Asia; 2001.

Saini R, Rai AK, Kesari A, Yar MS. Synthesis and biological evaluation of 2,5 di-

substituted 1,3,4-oxadiazoles. Asian j Research Chem. 2009;2:34-36.

Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions

and inflammation. Science. 1983;220:568-575.

Satoshkar RS, Bhandarkar SD, Rege NN. Pharmacology and

Pharmacotherapeutics, 20th

ed. Popular Prakashan, India; 2007.

Satyajit S and Lutfun N. Chemistry for pharmacy students: general, organic and

natural product chemistry. John Wiley & Sons; 2007

Sauers, Ronald R. Steric attraction: the far side. J Chem Edu. 1996;73:114.

Savariz FC, Formagio AS, Barbosa VA, Foglio MA, Carvalho JED, Duarte

MC, Filhoc BP, Sarragiotto MH. Synthesis, antitumor and antimicrobial activity

of novel 1-substituted phenyl-3-[3-alkylamino(methyl)-2-thioxo-1,3,4-oxadiazol-

5-yl]β-carboline derivatives. J Braz Chem Soc. 2010;21:288-298.

Selassie CD. History of quantitative structure activity relationships. Burger’s

Medicinal Chemistry and Drug Discovery. 6th

ed. John Wiley and Sons; 2003

Sengupta P, Mal M, Mandal S, Singh J, Maity TK. Evaluation of antibacterial and

antifungal activity of some 1,3,4-oxadiazoles. Iranian Journal of Pharmacology

and Therapeutics. 2008;7:165-167.

Seth SD. Text book of Pharmaology, 2nd

ed. Elsevier: A division of Reed Elsevier,

India; 2005.

Shaban MA, Nasr AZ, El-Badry SM. Synthesis and biological activities of some

1,3,4-oxadiazoles and bis(1,3,4-oxadiazoles). J Islam Acad Sci. 1991;4:184-191.

Shabani H, Ashrafi AR, Didea MV. Balaban index of an infinite class of

dendrimers, Croat Chem Acta. 2010; 83:439-442.

Shapiro R and Vallee BL. Interaction of human placental ribonuclease with

placental ribonuclease inhibitor. Biochem. 1991;30:2246–55.

Sharma MC, Kohli DV, Sahu NK, Sharma S, Chaturvedi SC. 2D-QSAR studies

of some 1,3,4-thiadiazole-2-yl azetidine-2-one as antimicrobial activity. Dig J

Nanomater Bios. 2009;4:339-347.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 243

Sharma S, Sharma PK, Kumar N, Dudhe R. A review: oxadiazole their chemistry

and pharmacological potentials. Der Pharma Chemica. 2010;2:253-263.

Shi W, Qian X, Song G, Zhang R, Li R. Synthesis and insecticidal activities of

novel 2-fluorophenyl-5-aryl/cyclopropyl-1,3,4-oxadiazoles. J Fluorine Chem.

2000;106:173-179.

Siddall PJ and Cousins MJ. Spine update: Spinal pain mechanisms. Spine.

1997;22:98-104.

Siddiqui AA, Islam M, Kumar S. Synthesis and antituberculostic activity of 5-{3’-

oxo-6’-(substituted phenyl)-2’,3’,4’,5’-tetrahydropyridazin-2’-yl}methyl-2-

substituted 1,3,4-oxadiazole. Der Pharmacia Lettre. 2010;2:319-327.

Silva CH and Taft CA. Molecular dynamics database screening, density functional

and docking studies of novel RAR ligand in cancer chemotherapy. Biophysical

Chem. 2005;117:73-77.

Singh IP, Saxena AK, Shankar K. Synthesis and anti-inflammatory activity of

oxadiazolines thione hydrochlorides. Eur J Med Chem. 1986;21:267–269.

Sivaraj S, Muthumani P, Venkataraman S, Raamamurthy J, Kumar RS. Design,

molecular docking, synthesis and evaluation of some novel heterocyclic analogues

of diclofenac as potent analgesic and anti-inflammatory agents with less

ulcerogenicity. Der Pharma Chemica. 2011;3:443-455.

Smeyers YG, Senen ML, Villa M, Theoretical structural & QSAR studies of some

arylpropionic acids as anti-inflammatory agents: an overview. Bio Appl Quantum

Chem Theory, 2002:1-15.

Smith WC, Neutrophils. In: Rich RR, Fleisher TA, Kotzin BL & Schroeder HW

(eds) Clinical Immunology. Principles and practice. Mosby International Limited,

London; 2001.

Smith WL and Willis AL. Aspirin selectively inhibits prostaglandin production in human

platelets. Nature. 1971;231:235-239.

Soni N, Barthwal JP, Saxena AK, Bhargava KP, Parmar SS. Monoamine oxidase

and succinate dehydrogenase inhibitory properties of substituted 1,3,4-oxadiazole-

2-thiones. J Heterocyclic Chem. 1982;19:29-32.

Srinivas K and Kumar KP. Synthesis, antimicrobial and anthelmintic activity of 1-

[(5-sustituted-1,3,4-oxadiazol-2-yl)methyl]-4-propylpiperazines. Int J Biopharm.

2010;1:14-19.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 244

Taiwo YO and Levine JD. Prostaglandin effects after elimination of indirect

hyperalgesic mechanisms in the skin of the rat, Brain Res. 1989;492:397-399.

Tan TM, Chen Y, Kong KH, J. Bai, Li Y, Lim SG, Ang TH, Lam Y. Synthesis

and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-

(1,3,4)-oxadiazoles as potential anti-hepatitis B virus agents. Antiviral Res.

2006;71:7-14.

Teplyakov A, Obmolova G, Badet M, Badet M. The mechanism of sugar

phosphate isomerization by glucosamine 6-phosphate synthase, Protein Sci.

1999;8:596-602.

Testa B and Jenner P. Drug metabolism, chemical and biochemical aspect, Marcel

Dekker inc., New York; 1976.

Thakur A, Thakur M, Kakani N, Joshi A, Thakur S, Gupta A. Application of

topological and physicochemical descriptors: QSAR study of phenylamino-

acridine derivatives. Arkivoc. 2004;xiv:36-43.

Thomas W. Shattuck, Colby college molecular mechanics tutorial. Introduction.

Chemical Computing Group, Canada; 2008

Thomsen R, Christensen MH. MolDock: A new technique for high-accuracy

molecular docking. J Med Chem. 2006;49:3315-3321.

Timothy JR. Solvent accessible surface area and excluded volume in proteins:

analytical equations for overlapping spheres and implications for the hydrophobic

effects. J Mol Bio. 1984;178:63-89.

Toliwal SD, Jadav K, Gupte A, Banu A. Synthesis and biological evaluation of

phenyl hydrazides and their derivatives from rice bran oil. Der Pharma Chemica.

2009;1:185-195.

Tramont EC and Hoover DL. Innate (general or nonspesific) host defence

mechanisms. In: Mandell GL, Bennett JE, Dolin R. Principles and practice of

infectious diseases. Churchill Livingstone, Philadelphia; 2000.

Tripathi KD. Essentials of Medicinal Chemistry. 2nd

ed. Jaypee Brothers Medical

Publishers. New Delhi, India; 2003.

Vander D, Tsai WA, Kulmacz AL. The cyclooxygenase reaction mechanism,

Biochem. 2002;41:15451-15458.

Vane JR and Botting RM. New insights into the mode of action of anti-

inflammatory drugs. Inflamm Res.1995;44:1-10.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 245

Vane JR, Prostaglandins as mediators of inflammation, Adv Prostaglandin

Thromboxane Res. 1976;2:791-780.

Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for

aspirin-like drugs. Nature. 1971;231:232-237.

Vanegas H and Schaible HG. Prostaglandins and cyclooxygenases in the spinal

cord. Prog Neurobiol. 2001;64:327-363.

Veerasamy R, Sivadasan S, Karupiah S, Arumugam DS. QSAR study of

substituted 1,3,4-oxadiazole naphthyridines as HIV-1integrase inhibitors. Eur J

Med Chem. 2010;45:2791-2797.

Venkatapuram P, Sanapalli RN, Konda M. Synthesis, antimicrobial and

antioxidant activities of sulfone linked bis heterocycles-pyrazolyl oxadiazoles and

pyrazolyl thiadiazole. Chem Pharm Bull. 2009; 57:1376-1380.

Vogel HG. Drug discovery and evaluation. Pharmacological assay. 2nd

Edition

Springer, New York; 2002.

Wang H, Kohno T, Nobuko I, Andrew A, Fumimas A, Gary BJ. Bradykinin

produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic

transmission. J Neuroscience. 2005;25:7986-92.

Warner TD and Giuliano F. Nonsteroid drug selectivities for cyclooxygenase-1

rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity:

A full in vitro analysis. Proc Natl Acad Sci. 1999;96:7563-7568.

Wedmore CV and Williams TJ. Control of vascular permeability by

polymorphonuclear leukocytes in inflammation. Nature. 1981;289:646-650.

Weiser ME. Atomic weights of elements. Pure Appl Chem. 2006;78:2051-2056.

Wiener H. Structural determination of paraffin boiling points. J Am Chem Soc.

1974;69:17-20.

Wilder-Smith CH. Predicting pain and pain responses to opioids. Eur J Pain

Suppl. 2007;1:31-31-37.

Williams JA and Shacter E. Regulation of macrophage cytokine production by

prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2. J Biol Chem.

1997;272:25693-25699.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 246

Winter A, Risley EA, Nuss GW. Carrageenan-induced oedema in hind paws of

the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol. 1962;111:544-

547.

Wojciechowski M, Mazerski J, Borowski E. Constrained search of conformational

hyperspace of inactivators of glucosamine-6-phosphate synthase. J Enzyme Inhib.

1996;10:17-26.

Wojciechowski M, Milewski S, Mazerski J, Borowski E, Glucosamine-6-

phosphate synthase, a novel target for antifungal agents-molecular modelling

studies in drug design. Acta Biochim Pol. 2005;52:647-653.

Wu J, Song B, Chen H, Bhadury P, Hu D. Synthesis and antifungal activity of 5-

chloro-6-phenylpyridazin-3(2H)-one derivatives. Molecules. 2009;14:3676-3687.

Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int

Rev Cytol. 1980;68:251-306.

Xu X, Zhu W, Zhang Y. The reductive reaction of substituted 2-chloromethyl-

1,3,4-oxadiazole to aldehydes and ketones promoted by samarium diiodide, Chin

Chem Lett. 2005;16:1566-1568.

Yang YH and Shi M. Halogen effects in Robinson-Gabriel type reaction of

cyclopropanecarboxylic acid N'-substituted-hydrazides with PPh3/CX4.

Tetrahedron Lett. 2005;46:6285-6288.

Yao X, Jericho M, Pink D, Beveridge T. Thickness and elasticity of gram-negative

murein sacculi measured by atomic force microscopy. J Bacterial. 1999;

181:6865-6875.

Yar MS, Siddiqui AA, Ali MA. Synthesis and anti tuberculostatic activity of

novel 1,3,4-oxadiazole derivatives. J Chinese Chem Soc. 2007;54:5-8.

Yasuyuki M, Takahiro N, Kenji S. Studies on pesticides for a rice plant

accumulation of oxadiazon and its metabolites in processed foods. Toxicol

Environ Chem. 1994;45:225- 235.

Yin L,

Xu W,

Wang Z,

Zhang D,

Jia J,

Ge Y, Li Y, Wang J. Synthesis and

antimicrobial activities of novel peptide deformylase inhibitors. Arkivoc.

2010;ix:196-205.

Yokomizo T, Izumi T, Shimizu T. Leukotriene B4: metabolism and signal

transduction. Arch Biochem Biophys. 2001;385:231-241.

Chapter-8 References

Faculty of Pharmaceutical Sciences, M.M. University, Mullana, Ambala, Haryana (India) 247

Zahid M,

Yasin KA, Akhtar T, Rama NH,

Hameed S,

Al-Masoudi NA, Loddo R,

Colla PL. Synthesis and in vitro antiproliferative activity of new

adamantylthiazolyl-1,3,4-oxadiazoles. Arkivoc. 2009;xi:85-93.

Zarghi A, Hamedi S, Tootooni F, Amini B, Sharifi B, Faizi M, Tabatabai SA,

Shafiee A. Synthesis and pharmacological evaluation of new 2-substituted-5-{2-

[(2-halobenzyl)thio)phenyl}-1,3,4-oxadiazoles as anticonvulsant agents. Sci

Pharm. 2008; 76:185-201.

Zarghi A, Tabatabai SA, Faizi M, Ahadian A, Navabi P, Zanganeh V, Shafiee A.

Synthesis and anticonvulsant activity of new 2-substituted-5-(2-

benzyloxyphenyl)-1,3,4-oxadiazole. Bioorg Med Chem Lett. 2005;15:1863-1865.